Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 248-326-4 | CAS number: 27213-90-7
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1970
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The test item has been administered to rats at dose of 400, 800, 1600, 2000, 2500 e 3200 mg/kg bw by gavage.
- GLP compliance:
- no
- Test type:
- acute toxic class method
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Doses:
- 400, 800, 1600, 2000, 2500 e 3200 mg/kg bw
- No. of animals per sex per dose:
- 400 mg/kg bw: 10 males and 10 females
800 mg/kg bw: 10 males and 10 females
1600 mg/kg bw: 20 males and 20 females
2000 mg/kg bw: 10 males and 10 females
2500 mg/kg bw: 10 males and 10 females
3200 mg/kg bw: 10 males and 10 females - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 800 mg/kg bw
- Based on:
- test mat.
- Interpretation of results:
- harmful
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- DL50 in male/female rats: 1800 mg/ kg bw
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 800 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1987
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- GLP compliance:
- no
- Test type:
- acute toxic class method
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Route of administration:
- inhalation
- Type of inhalation exposure:
- nose/head only
- Duration of exposure:
- 4 h
- Concentrations:
- Group 1: 1.09 mg/L
Group 2: 3.49 mg/l
Group 3: 4.76 mg/L - No. of animals per sex per dose:
- 5 males and 5 females
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 3.82 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- LC50 for male and female rats is 3.82 mg/L/4h
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 3 820 mg/m³ air
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1970
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The test item has been administered to rats at dose of 1000, 2000 and 4000 mg/kg bw.
- GLP compliance:
- no
- Test type:
- standard acute method
- Species:
- rabbit
- Strain:
- Vienna White
- Sex:
- male/female
- Vehicle:
- water
- Duration of exposure:
- 24 hours
- Doses:
- 1000, 2000 and 4000 mg/kg bw
- No. of animals per sex per dose:
- 1000 mg/kg: 2 males and 1 female
2000 mg/kg: 2 females and 1 male
4000 mg/kg: 4 males and 2 females - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 3 000 mg/kg bw
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- LD50 for male/female rabbits is 3000 mg/kg.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 3 000 mg/kg bw
Additional information
The L(E)C50 values obtained in the experimental studies for substances with different CAS numbers are comparable by read-across.
Justification for selection of acute toxicity – oral endpoint
The two available experimental studies report similar results, which involve the same hazard classififcation.
Justification for selection of acute toxicity – inhalation endpoint
The selected study is the only study reporting an exact LC50 value.
Justification for selection of acute toxicity – dermal endpoint
The selected study is the only available for the dermal route.
Justification for classification or non-classification
Basing on the L(E)C50 values and according to Regulation 1272/2008/EC, the substance is classified as follows:
Acute Tox. 4, H302
Acute Tox. 4, H332
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
